The greatest burdens related to human onchocerciasis are the result of
the eye and skin lesions and severe itching produced by the microfila
riae. Although the major manifestations of the disease do show geograp
hical variation (e.g. onchocercal blindness is not a common complicati
on in all endemic countries), they are often sufficiently severe to pr
event human use of the often very fertile land close to the rivers in
which the vectors breed. Though for many years thought to be of relati
vely minor importance compared with onchocercal eye disease, the skin
lesions of onchocerciasis have recently been shown to be a major socio
-economic burden, in terms of disability-adjusted life-years. The demo
nstration of an excellent correlation between the prevalence of palpab
le nodules in a community and the community microfilarial load has led
to the development of rapid, safe and non-invasive methods to assess
and map the levels of endemicity across whole countries. This has enab
led mass treatment with Mectizan (ivermectin, MSD) to be targeted firs
t at hyperendemic communities. Estimates of the burden of onchocercias
is will continue to change as better means of measurement become avail
able. It seems possible, however, that use of Mectizan will eliminate
the disease before its true burden can be estimated accurately.